You are here:
03 February 2015
Co-financing means that countries contribute to the cost of Gavi-supported vaccines by procuring some of the required vaccine doses with non-Gavi funds.
Country eligibility policy
Please note that the Gavi Board approved a new Eligibility & Transition policy which came into effect on 1 July 2015 and replaces the Eligibility policy on this page. This page will be updated shortly. In the meantime, the new policy can be found here | [French].
05 March 2013
Gavi policy on fragility and immunisation
In December 2012, the Gavi Board approved a policy that allows tailored approaches to be applied to fragile states and time-limited responses to be extended to countries in short-term emergency situations, with the aim to improve or protect immunisation systems in Gavi-supported countries. The policy enables Gavi to work with our partners to strengthen our focus on countries that require more intensive support and attention.
07 March 2011
Gavi has committed to increasing immunisation coverage by 1) supporting countries to overcome gender-related barriers to accessing immunisation services and 2) promoting equity of access and utilisation for all girls and boys, women and men to immunisation and related health services that respond to their different health needs.
Please note that the Gavi Board approved a new Eligibility & Transition policy which came into effect on 1 July 2015 and replaces the Graduation policy on this page. This page will be updated shortly. In the meantime, the new policy can be found here | [French].
In June 2013, the Gavi Board reviewed the mechanism which allows the ranking of technically sound proposals from Gavi-eligible countries and the subsequent prioritisation of funding choices in case of insufficient resources.
01 October 2015
The risk policy forms the overarching framework for Gavi’s risk management approach. It is embedded in various structures and processes for risk monitoring, reporting and mitigation.
18 March 2013
This policy outlines how countries opting for self-procurement should only use Gavi funds to purchase vaccines and related injection safety supplies (auto-disable syringes, syringe and needle disposal boxes) that meet international expectations of assured quality.
01 April 2011
Transparency and accountability policy
If Gavi is to deliver on its mission, it must take some risk, and do everything possible to mitigate that risk. Donors realise this, but also rightly expect risks to be minimised and action to be taken when misuse is uncovered.
Vaccine donation policy
Donations of vaccines by industry to international organisations or to governments can bring benefits if properly managed, but also carry certain risks. Gavi only accepts vaccines donations under exceptional circumstances and requires both the manufacturer and recipient country to comply with a number of conditions.
19 June 2012
Vaccine introduction grants and operational support for campaigns policy
Gavi provides a cash grant to countries ahead of each new vaccine introduction to facilitate the timely and effective implementation of critical preparation activities. Gavi also provides cash support to cover a share of the delivery cost of vaccination campaigns.
Eligibility & Transition policy
Eligibility & Transition policy [French]
From 5 to 15 vaccine manufacturers supplying Gavi – from 1 to 8 based in emerging markets.
2001: 5 vaccine manufacturers - 1 based in an emerging market;
Mid 2015: 15 vaccine manufacturers – 8 based in emerging markets.
Concerned about the misuse of Gavi resources? Report it now.
© Gavi 2016
modal window here